Publications by authors named "Kayo Kayahashi"

Article Synopsis
  • Low estrogen levels are thought to suppress uterine endometrial carcinoma, yet most cases arise after menopause, prompting a focus on declining androgen levels as a potential factor in its progression.
  • The study examines the role of androgen and its receptor (AR) by analyzing clinical data, culturing cancer cell lines, and using murine models, showing that higher androgen receptor expression and dihydrotestosterone (DHT) levels correlate with lower disease-free survival.
  • DHT reduces cancer cell proliferation and suppresses FOXP4 expression, suggesting that the androgen/AR system can inhibit malignant behavior in endometrial carcinoma, pointing to FOXP4 as a key target for future clinical strategies.
View Article and Find Full Text PDF

Although adenomyosis is a benign uterine disease, it can turn malignant in rare instances. Cystic adenomyosis is a rare variation of adenomyosis, arising from which 8 cases of clear cell carcinoma have been reported. However, to the best of our knowledge, there have been no previous reports describing the mechanism by which clear cell carcinoma develops from cystic adenomyosis.

View Article and Find Full Text PDF

Background: Since the human papillomavirus vaccines do not eliminate preexisting infections, nonsurgical alternative approaches to cervical intraepithelial neoplasia (CIN) have been required. We previously reported that FOXP4 (forkhead box transcription factor P4) promoted proliferation and inhibited squamous differentiation of CIN1-derived W12 cells. Since it was reported that FOXP expressions were regulated by the androgen/androgen receptor (AR) complex and AR was expressed on the CIN lesions, in this study we examined the effects of androgen on CIN progression.

View Article and Find Full Text PDF

Background: Aberrant expression of P-cadherin has been reported in various cancers, and has been attracting attention as a target for cancer treatment. Ovarian cancer, the leading cause of death among gynecologic malignancies, is classified into four histological subtypes: serous, mucinous, endometrioid, and clear cell, and each has distinct biological behavior. Although a negative survival impact in serous ovarian cancer patients and some functional role in peritoneal dissemination have been reported, differences of P-cadherin expression in histological subtypes and the proportion and distribution of positive cells remain to be investigated.

View Article and Find Full Text PDF

Recent reports showed that neoadjuvant chemotherapy (NAC) has been successfully applied to treat advanced uterine cervical cancers during pregnancy. However, its side effects on the fetus remain unclear. Here, we report a 33-year-old primipara who underwent four courses of NAC therapy, paclitaxel and cisplatin, from 17 to 27 weeks of gestation due to uterine cervical cancer stage IB2.

View Article and Find Full Text PDF

Gastric metastasis from ovarian cancer is exceptionally rare and generally occurs in advanced stages. A 71-year-old woman presented with a solitary gastric submucosal mass 8 years after the diagnosis of a stage IA ovarian serous adenocarcinoma. Endoscopy showed a tumor covered with normal gastric mucosa.

View Article and Find Full Text PDF